Fatty Liver Clinical Trials

Find clinical trials for Fatty Liver. Search for Fatty Liver clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 81

GuselkumabElucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

Recruiting

Sponsor:

UCLA

Location:

San Diego CA

Code:

NCT06586281

Conditions

Psoriatic Arthritis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Guselkumab

Vertical Sleeve Gastrectomy & Lifestyle ModificationVertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis

Recruiting

Sponsor:

University of Minnesota

Location:

San Francisco CA, Minneapolis MN

Code:

NCT03587831

Conditions

NASH - Nonalcoholic Steatohepatitis

Eligibility Criteria

Sex: All

Age: 30 - 70

Healthy Volunteers: Not accepted

Interventions

Vertical Sleeve Gastrectomy

Lifestyle Modification Counseling

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Homewood AL, Chandler AZ, Flagstaff AZ, Peoria AZshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

DiazoxideGlycemic Effect of Diazoxide in NAFLD

Recruiting

PHASE1

Sponsor:

Columbia University

Location:

New York NY

Code:

NCT05729282

Conditions

Hyperinsulinemia

Insulin Resistance

Non-Alcoholic Fatty Liver Disease

Prediabetic State

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Diazoxide oral suspension, 1 mg per kg per dose

Diazoxide oral suspension, 2 mg per kg per dose

Placebo

FreeStyle Libre Pro

Deuterated water (2H2O/D2O)

Observational StudyA Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Phoenix AZ, Palo Alto CA, Pasadena CA, Sacramento CAshow 52 more

Code:

NCT02815891

Conditions

Nonalcoholic Fatty Liver

Nonalcoholic Steatohepatitis

Eligibility Criteria

Sex: All

Age: 2+

Healthy Volunteers: Not accepted

Pulmonary Arterial HypertensionRight Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

Recruiting

Sponsor:

Vanderbilt University Medical Center

Location:

Nashville TN

Code:

NCT05462574

Conditions

Idiopathic Pulmonary Arterial Hypertension

Heritable Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

No Intervention

Diabetes PreventionDiabetes Prevention and Education

Recruiting

Sponsor:

University of Maryland, Baltimore

Location:

Baltimore MD

Code:

NCT05769127

Conditions

Diabetes

Pre Diabetes

Fatty Liver

Body Weight Changes

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Diabetes Prevention Program (DPP), Diabetes Self-Management Training (DSMT)

Amino AcidsEffect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)

Recruiting

PHASE3

Sponsor:

University of Colorado, Denver

Location:

Aurora CO

Code:

NCT05935826

Conditions

Hepatic Steatosis

NAFLD

Adolescent Obesity

Eligibility Criteria

Sex: All

Age: 13 - 18

Healthy Volunteers: Not accepted

Interventions

Essential Amino Acid Supplement by Amino Co

Placebo

StatinsStatins for the Treatment of NASH

Recruiting

PHASE2

Sponsor:

Mayo Clinic

Location:

Rochester MN, Durham NC

Code:

NCT04679376

Conditions

NASH - Nonalcoholic Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Atorvastatin

Placebo

Polyphenol SupplementationEffect of Polyphenol Supplementation on Hepatic Steatosis and Vascular Compliance

Recruiting

Sponsor:

St. Justine's Hospital

Location:

Montreal

Code:

NCT03994029

Conditions

Obesity, Childhood

Hepatic Steatosis

Intimal Hyperplasia

Eligibility Criteria

Sex: All

Age: 12 - 18

Healthy Volunteers: Not accepted

Interventions

Effect of polyphenols on hepatic steatosis and vascular elastography and intima media thickness